Thompson Peter A.

CIK 000135752217 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001357522

Recent Transactions

50 trades

Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-07-07$44.86/sh−85,918→ 2,469,959 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-06-30$45.50/sh−115,844→ 2,555,877 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2026-06-24+30,000→ 30,000 total
Award
Sionna Therapeutics, Inc.$SION
Non-Qualified Stock Option (right to buy)
2026-06-17+17,340→ 17,340 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-06-11+15,000→ 15,000 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2026-06-05+16,377→ 16,377 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-05-27$44.49/sh−101→ 2,671,721 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-05-11$46.22/sh−184,639→ 2,671,822 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-05-08$44.58/sh−59,767→ 2,856,461 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-05-07$44.61/sh−48,546→ 2,916,228 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-04-18$44.52/sh−2,948→ 2,964,774 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-04-17$44.68/sh−52,397→ 2,967,722 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-04-16$45.34/sh−226,906→ 3,020,119 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-04-15$44.64/sh−235,863→ 3,247,025 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-04-14$44.51/sh−47,814→ 3,482,888 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-02-03$44.58/sh−29,063→ 3,530,702 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2026-02-02$44.57/sh−1,890→ 3,559,765 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−15,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−15,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$3.27/sh+15,000→ 105,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−15,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−15,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$0.99/sh+15,000→ 150,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$2.60/sh+15,000→ 135,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$3.61/sh+15,000→ 75,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$2.49/sh+15,000→ 180,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$1.64/sh+15,000→ 195,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$15.00/sh+30,000→ 30,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$9.70/sh+15,000→ 45,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−15,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−15,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$2.12/sh+15,000→ 210,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−15,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−30,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−15,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−15,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$2.74/sh+15,000→ 120,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−15,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−15,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2026-01-28−15,000→ 0 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$12.50/sh+15,000→ 60,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$0.96/sh+15,000→ 165,000 total
Exercise/Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2026-01-28$2.00/sh+15,000→ 90,000 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-12-19$44.49/sh−875→ 3,595,011 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-12-18$44.49/sh−100→ 3,595,886 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-12-17$44.50/sh−900→ 3,595,986 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-11-26$44.49/sh−1,600→ 3,596,886 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-11-25$44.60/sh−11,890→ 3,598,486 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-11-24$44.54/sh−94,583→ 3,610,376 total
Sale
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2025-06-27$4.16/sh−1,176,332→ 7,165,006 total

Companies

Recent Filings

Address

C/O SIONNA THERAPEUTICS, INC. 21 HICKORY DRIVE, SUITE 500

WALTHAM, MA, 02451

View on SEC.gov